- Filed
- Jun 12, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | FY 2025 · Jun 12, 2025 | 2.39M sh |
| Shares Diluted restated | FY 2025 · Mar 31, 2024 | 2.38M sh |
| Capex | FY 2025 · Mar 31, 2024 | $347.17K |
| Operating Cash Flow | FY 2025 · Mar 31, 2024 | −$1.91M |
| Cash And Equivalents | FY 2025 · Mar 31, 2024 | $6.14M |
| Current Liabilities | FY 2025 · Mar 31, 2024 | $2.88M |
| Total Liabilities | FY 2025 · Mar 31, 2024 | $5.11M |
| Current Assets | FY 2025 · Mar 31, 2024 | $21.17M |
| Total Assets | FY 2025 · Mar 31, 2024 | $26.91M |
| Eps Diluted | FY 2025 · Mar 31, 2024 | −$1.23 |
| Eps Basic | FY 2025 · Mar 31, 2024 | −$1.23 |
| Sga Expense | FY 2025 · Mar 31, 2024 | $6.16M |
| Net Income | FY 2025 · Mar 31, 2024 | −$2.92M |
| Operating Income | FY 2025 · Mar 31, 2024 | −$3.76M |
| Revenue | FY 2025 · Mar 31, 2024 | $21.52M |
| Stockholders Equity | FY 2025 · Mar 31, 2023 | $24.32M |